LEGEND BIOTECH CORP

Legend Biotech’s interim CEO buys 4,908 shares at $0, signaling confidence in the undervalued stock and a potential rally amid declining share price.

Legend Biotech insiders sell shares amid volatile biotech market—what it means for investor confidence and future prospects.

Legend Biotech CEO’s recent share sale is a routine tax event, not a warning—insiders stay passive while the company focuses on oncology cell‑therapy.